Suven Life Sciences Ltd
Chinnapillai Rajendiran has over two decades of experience in the pharmaceutical industry. CHINNAPILLAI started their career at Natco Pharma Limited in India in 1993, where they served as a Senior Scientist in R&D for five years. In 1998, they joined Sun Pharma as a Senior Manager until 2002. In this role, they held responsibilities in R&D. In 2002, they joined Suven Life Sciences Limited as Vice President of R&D, where they currently work.
CHINNAPILLAI RAJENDIRAN attended Presidency College from 1981 to 1990. No specific degree or field of study information is provided.
This person is not in the org chart
This person is not in any offices
Suven Life Sciences Ltd
1 followers
Suven Life Sciences Limited is a bio-pharmaceutical company. The Company is engaged in the business of manufacture and sale of bulk drugs and intermediaries. The Company's segments include Manufacturing (CRAMS), which develops and produces bulk drugs and intermediates under contract manufacturing services; Services (DDDSS), which consists of collaborative research projects (CRP), clinical trials, and testing and analysis services, and Research and Development. Its products consist of active pharmaceutical ingredients (APIs), including Aripiprazole, Armodafinil, Calcium Acetate, Carprofen, Deferasirox, Doxofylline, Entacapone, Fenoprofen Calcium, Rosuvastatin Calcium, Sitagliptin Phosphate and Solifenacin succinate, and intermediates, including 2-nitro phenyl acetic acid and 3, 4-dichlorobenzylamine. The Company is engaged in the drug discovery specializing in central nervous system (CNS)-based programs with over four of the molecules in pipeline under clinical phase of development.